{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:44:49Z","timestamp":1771047889383,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:00:00Z","timestamp":1734566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis Imaging"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ostima.2024.100259","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T19:24:46Z","timestamp":1734722686000},"page":"100259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Perspective: Empowering osteoarthritis drug development through assessment of synovitis by CE-MRI: A new approach in clinical trials"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8252-7815","authenticated-orcid":false,"given":"Francis","family":"Berenbaum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ostima.2024.100259_bib0001","doi-asserted-by":"crossref","first-page":"e508","DOI":"10.1016\/S2665-9913(23)00163-7","article-title":"Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"5","author":"Steinmetz","year":"2023","journal-title":"Lancet Rheumatol."},{"issue":"1","key":"10.1016\/j.ostima.2024.100259_bib0002","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2011-000435","article-title":"What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients","volume":"2","author":"Beswick","year":"2012","journal-title":"BMJ Open."},{"key":"10.1016\/j.ostima.2024.100259_bib0003","first-page":"56","article-title":"FDA\/Arthritis Foundation osteoarthritis drug development workshop recap: assessment of long-term benefit","author":"Kim","year":"2022","journal-title":"Semin. Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.ostima.2024.100259_bib0004","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.joca.2018.11.002","article-title":"Proposed study designs for approval based on a surrogate endpoint and a post-marketing confirmatory study under FDA's accelerated approval regulations for disease modifying osteoarthritis drugs","volume":"27","author":"Kraus","year":"2019","journal-title":"OsteoArthritis Cartilage"},{"key":"10.1016\/j.ostima.2024.100259_bib0005","unstructured":"Reasonably Likely Surrogate Endpoint - BEST (Biomarkers, EndpointS, and other Tools) Resource - NCBI Bookshelf [Internet]. [cited 2024 May 13]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK453485\/."},{"key":"10.1016\/j.ostima.2024.100259_bib0006","unstructured":"Accelerated Approval | FDA [Internet]. [cited 2024 May 13]. Available from: https:\/\/www.fda.gov\/patients\/fast-track-breakthrough-therapy-accelerated-approval-priority-review\/accelerated-approval."},{"issue":"14","key":"10.1016\/j.ostima.2024.100259_bib23","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.3390\/jcm11143985","article-title":"Time to total knee arthroplasty after intra-articular hyaluronic acid or platelet-rich plasma injections: a systematic literature review and meta-analysis","volume":"11","author":"Berkani","year":"2022","journal-title":"J. Clin. Med."},{"issue":"8","key":"10.1016\/j.ostima.2024.100259_bib0007","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/annrheumdis-2020-217363","article-title":"Does cartilage loss cause pain in osteoarthritis and if so, how much?","volume":"79","author":"Bacon","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ostima.2024.100259_bib0008","first-page":"221","article-title":"The genesis of pain in osteoarthritis: inflammation as a mediator of osteoarthritis pain","volume":"38","author":"Wood","year":"2022","journal-title":"Clin Ger Med"},{"issue":"9","key":"10.1016\/j.ostima.2024.100259_bib0009","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.joca.2022.06.004","article-title":"Synovitis mediates the association between bone marrow lesions and knee pain in osteoarthritis: data from the Foundation for the National Institute of Health (FNIH) Osteoarthritis Biomarkers Consortium","volume":"30","author":"Wang","year":"2022","journal-title":"OsteoArthritis Cartilage"},{"key":"10.1016\/j.ostima.2024.100259_bib0010","first-page":"258","article-title":"Synovial inflammation in osteoarthritis progression. Vol. 18, nature reviews rheumatology","author":"Sanchez-Lopez","year":"2022","journal-title":"Nature Research"},{"issue":"10","key":"10.1016\/j.ostima.2024.100259_bib0011","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1136\/ard.2009.121426","article-title":"Relation of synovitis to knee pain using contrast-enhanced MRIs","volume":"69","author":"Baker","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.ostima.2024.100259_bib0012","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/art.30148","article-title":"Fluctuation of knee pain and changes in bone marrow lesions, effusions, and synovitis on magnetic resonance imaging","volume":"63","author":"Zhang","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.ostima.2024.100259_bib0013","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1148\/radiol.14140991","article-title":"Can structural joint damage measured with mr imaging be used to predict knee replacement in the following year?","volume":"274","author":"Roemer","year":"2015","journal-title":"Radiology."},{"issue":"8","key":"10.1016\/j.ostima.2024.100259_bib0014","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/art.39176","article-title":"What comes first? Multitissue involvement leading to radiographic osteoarthritis: magnetic resonance imaging-based trajectory analysis over four years in the osteoarthritis initiative","volume":"67","author":"Roemer","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"10.1016\/j.ostima.2024.100259_bib0015","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/art.39731","article-title":"Semiquantitative imaging biomarkers of knee osteoarthritis progression: data from the foundation for the national institutes of health osteoarthritis biomarkers consortium","volume":"68","author":"Collins","year":"2016","journal-title":"Arthritis and Rheumatology"},{"issue":"1","key":"10.1016\/j.ostima.2024.100259_bib0016","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.40660","article-title":"Association of changes in effusion-synovitis with progression of cartilage damage over eighteen months in patients with osteoarthritis and meniscal tear","volume":"71","author":"MacFarlane","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.ostima.2024.100259_bib0017","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.joca.2005.01.005","article-title":"Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis - Results of a 1 year longitudinal arthroscopic study in 422 patients","volume":"13","author":"Ayral","year":"2005","journal-title":"OsteoArthritis Cartilage"},{"issue":"2","key":"10.1016\/j.ostima.2024.100259_bib0018","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/annrheumdis-2014-205894","article-title":"Synovitis in knee osteoarthritis: a precursor of disease?","volume":"75","author":"Atukorala","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ostima.2024.100259_bib0019","first-page":"126","article-title":"Are contrast-enhanced and non-contrast MRI findings reflecting synovial inflammation in knee osteoarthritis: a meta-analysis of observational studies","volume":"28","author":"Shakoor","year":"2020"},{"key":"10.1016\/j.ostima.2024.100259_bib0020","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1007\/s00330-021-07698-z","article-title":"Dynamic contrast-enhanced MRI of synovitis in knee osteoarthritis: repeatability, discrimination and sensitivity to change in a prospective experimental study","volume":"31","author":"Mackay","year":"2021","journal-title":"Eur. Radiol."},{"issue":"3","key":"10.1016\/j.ostima.2024.100259_bib24","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.23.30036","article-title":"Update on gadolinium-based contrast agent safety, from the AJR special series on contrast media","volume":"223","author":"Starekova","year":"2024","journal-title":"Am. J. Roentgenol."},{"issue":"3","key":"10.1016\/j.ostima.2024.100259_bib0021","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2214\/AJR.21.26170","article-title":"Imaging of synovial inflammation in osteoarthritis, from the AJR special series on inflammation","volume":"218","author":"Thoenen","year":"2022","journal-title":"Am. J. Roentgenol."},{"issue":"10","key":"10.1016\/j.ostima.2024.100259_bib0022","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1136\/ard.2011.150243","article-title":"Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study","volume":"70","author":"Roemer","year":"2011","journal-title":"Ann. Rheum. Dis."}],"container-title":["Osteoarthritis Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277265412400093X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277265412400093X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T23:10:49Z","timestamp":1745017849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277265412400093X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S277265412400093X"],"URL":"https:\/\/doi.org\/10.1016\/j.ostima.2024.100259","relation":{},"ISSN":["2772-6541"],"issn-type":[{"value":"2772-6541","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perspective: Empowering osteoarthritis drug development through assessment of synovitis by CE-MRI: A new approach in clinical trials","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ostima.2024.100259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society of Osteoarthritis Imaging.","name":"copyright","label":"Copyright"}],"article-number":"100259"}}